［1］Lindner M, Gramer G, Haege G, Fang-Hoffmann J, Schwab KO, Tacke U, et al. Eficacy and outcome of expanded newborn screening for metabolic diseases—report of 10 years from South-West Germany［J］. Orphanet J Rare Dis, 2011, 6: 44.
［2］Amat di San Filippo C, Taylor MR, Mestroni L, Botto LD, Longo N. Cardiomyopathy and carnitine deficiency［J］. Mol Genet Metab, 2008, 94(6): 162-166.
［4］Lund AM, Joensen F, Hougaard DM, Jensen LK, Christensen E, Christensen M, et al. Carnitine transporter and holocarboxylase synthetase deficiencies in the Faroe Islands［J］. J Inherit Metab Dis, 2007, 30(3): 341-349.
［5］Roe CR, Coates PM. Mitochondrial fatty acid oxidation disorders［M］// Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease.New York, McGraw-Hill, 1995: 1501-1533.
